SAN ANTONIO – The U.S. Food and Drug Administration has granted Xenex Disinfection Services a De Novo authorization for its LightStrike+ device. That decision is expected to significantly drive up demand for the San Antonio-based company’s germ-zapping robots. The Xenex machines utilize high-intensity, broad-spectrum ultraviolet light to reduce potentially deadly…Read More
Related Posts
Recursion to Participate in Upcoming Investor Conferences Recursion Pharmaceuticals NASDAQRXRX
SALT LAKE CITY, June 01, 2023 (GLOBE NEWSWIRE) -- Recursion RXRX, a clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor…
Palisade Bio Announces Completion of Enrollment in LB1148 Dose Optimization Study
Carlsbad, CA, July 05, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (the "Company"), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced the…
Pet Ultrasound Devices to Reinforce Veterinary Imaging Instrument Industry Growth Grand View Research Inc
SAN FRANCISCO, April 6, 2023 /PRNewswire/ -- The global veterinary imaging instrument industry size was valued at USD 1.44 billion in 2021 and will exhibit a CAGR of 5.7% from…
